COVID-19 Booster Dose Reminder/Recall for Adolescents

Marshfield Clinic Research Foundation4,304 enrolled

Overview

A single COVID-19 booster dose has been recommended in the United States for adolescents aged ≥12 years to enhance protection against SARS-CoV-2 infection. This study will assess the efficacy of a one-time reminder/recall for COVID-19 booster dose among eligible adolescents in a regional healthcare system.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

4,304

Conditions

COVID-19 Vaccines

Interventions

Reminder/Recall Sent Via Preferred Method of CommunicationBEHAVIORAL

Parents of 12-17 year-old patients due for COVID-19 booster dose will receive a one-time vaccine reminder/recall via the parent's preferred method of communication (mailed letter, text message, email)

Eligibility

Sex: ALLMin age: 12 YearsMax age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Marshfield Clinic Health System patient aged 12-17 years with at least one preventive visit or two evaluation \& management visits with a Marshfield Clinic Health System provider in the last 36 months * Due for a COVID-19 booster dose (completed the COVID-19 primary series and it has been ≥5 months since their second dose) Exclusion Criteria: * Primary care provider is not affiliated with Marshfield Clinic Health System * Opted out of Marshfield Clinic Health System centralized vaccine reminder notifications * Received COVID-19 vaccine off label * Missing or invalid contact information * Deceased

Locations (1)

Marshfield Clinic Health System

Marshfield, Wisconsin, United States

Outcomes

Primary Outcomes

COVID-19 Booster Dose

Number of patients that received a COVID-19 booster dose during follow-up based on electronic health data. Receipt of a COVID-19 booster dose within 90 days of randomization (yes/no) will be assessed using vaccination data available from the Marshfield Clinic Health System (MCHS) electronic health record, which includes vaccinations administered outside of MCHS through data exchanges with the Wisconsin Immunization Registry. Specifically patients will be classified as having received a COVID-19 booster dose if they have record of receipt of COVID-19 booster dose with a vaccination date during the 90-day follow-up period.

Time frame: 90 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.